Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC)
Thailand · Delayed Price · Currency is THB 3.340
+0.020 (0.60%)
Jun 5, 2026, 4:37 PM ICT
BKK:AMARC Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 493.1 | 491.01 | 344.85 | 289.21 | 263.22 | 245.95 |
Other Revenue | 3.69 | 3.65 | 4.24 | 4.64 | 1.04 | 2.6 |
| 496.79 | 494.66 | 349.09 | 293.85 | 264.26 | 248.55 | |
Revenue Growth (YoY) | 32.44% | 41.70% | 18.80% | 11.20% | 6.32% | 12.88% |
Cost of Revenue | 228.86 | 225.72 | 205.4 | 180.74 | 158.17 | 141.02 |
Gross Profit | 267.93 | 268.94 | 143.69 | 113.11 | 106.09 | 107.53 |
Selling, General & Admin | 111.26 | 110.67 | 102.31 | 97.33 | 81.98 | 73.16 |
Operating Expenses | 111.26 | 110.67 | 102.31 | 97.33 | 81.98 | 73.16 |
Operating Income | 156.68 | 158.27 | 41.38 | 15.78 | 24.12 | 34.37 |
Interest Expense | -0.81 | -0.96 | -1.82 | -2.83 | -6.17 | -6.89 |
Earnings From Equity Investments | - | - | - | -0.33 | - | - |
Pretax Income | 155.87 | 157.31 | 39.56 | 12.61 | 17.94 | 27.48 |
Income Tax Expense | -1.97 | -1.25 | -0.34 | 2.97 | 3.43 | 2.62 |
Net Income | 157.84 | 158.56 | 39.9 | 9.64 | 14.52 | 24.86 |
Net Income to Common | 157.84 | 158.56 | 39.9 | 9.64 | 14.52 | 24.86 |
Net Income Growth | 176.36% | 297.41% | 313.70% | -33.56% | -41.62% | -12.53% |
Shares Outstanding (Basic) | 420 | 420 | 420 | 420 | 327 | 300 |
Shares Outstanding (Diluted) | 420 | 420 | 420 | 420 | 327 | 300 |
Shares Change (YoY) | -0.09% | - | - | 28.46% | 8.99% | - |
EPS (Basic) | 0.38 | 0.38 | 0.09 | 0.02 | 0.04 | 0.08 |
EPS (Diluted) | 0.38 | 0.38 | 0.09 | 0.02 | 0.04 | 0.08 |
EPS Growth | 176.61% | 297.41% | 313.71% | -48.28% | -46.43% | -12.53% |
Free Cash Flow | 153.54 | 157.96 | 57.66 | -12.59 | 32.75 | 54.38 |
Free Cash Flow Per Share | 0.37 | 0.38 | 0.14 | -0.03 | 0.10 | 0.18 |
Dividend Per Share | 0.250 | 0.250 | 0.060 | 0.039 | 0.100 | 0.050 |
Dividend Growth | 316.67% | 316.67% | 53.85% | -61.00% | 100.00% | 100.00% |
Gross Margin | 53.93% | 54.37% | 41.16% | 38.49% | 40.15% | 43.26% |
Operating Margin | 31.54% | 32.00% | 11.85% | 5.37% | 9.13% | 13.83% |
Profit Margin | 31.77% | 32.05% | 11.43% | 3.28% | 5.49% | 10.00% |
Free Cash Flow Margin | 30.91% | 31.93% | 16.52% | -4.29% | 12.39% | 21.88% |
EBITDA | 191.47 | 194.28 | 75.82 | 20.45 | 53.3 | 58.99 |
EBITDA Margin | 38.54% | 39.27% | 21.72% | 6.96% | 20.17% | 23.73% |
D&A For EBITDA | 34.8 | 36.01 | 34.44 | 4.67 | 29.18 | 24.61 |
EBIT | 156.68 | 158.27 | 41.38 | 15.78 | 24.12 | 34.37 |
EBIT Margin | 31.54% | 32.00% | 11.85% | 5.37% | 9.13% | 13.83% |
Effective Tax Rate | - | - | - | 23.54% | 19.11% | 9.52% |
Revenue as Reported | 496.79 | 494.66 | 349.09 | 293.85 | 264.26 | 248.55 |